Month: May 2010

Survey: Most patients with HIV lipodystrophy are willing to inject Egrifta once a day to reduce their visceral fat

 LIPODYSTROPHY TREATMENT- PATIENT ACCEPTANCE DownloadCreate Chart1. Has your belly fat increased after starting HIV medications? answered question 85 skipped question 2 Response Percent Response Count Yes 92.9% 79 No 7.1% 6 DownloadCreate Chart2. Would you be willing to inject a drug daily under your skin in your belly to decrease your belly fat by 13% …

Survey: Most patients with HIV lipodystrophy are willing to inject Egrifta once a day to reduce their visceral fat Read More »

Impact of Lipodystrophy on Quality of Life of People Living With HIV- Survey Results

1. How old are you? answered question 1,325 skipped question 6 ResponsePercent ResponseCount Under 15 years old 0.3% 4 15-20 0.2% 2 20-25 0.5% 7 25-30 1.7% 23 30-35 4.8% 63 35-40 7.8% 104 40-45 23.1% 306 45-50 22.6% 299 50-55 20.8% 275 55-60 11.4% 151 Over 60 6.9% 91 DownloadCreate Chart2. What is your …

Impact of Lipodystrophy on Quality of Life of People Living With HIV- Survey Results Read More »

FDA Committee Unanimously Recommends Egrifta for Lipodystrophy

FROM POZ.COM May 27, 2010 FDA Committee Unanimously Recommends Egrifta for Lipodystrophy A U.S. Food and Drug Administration (FDA) advisory committee has unanimously recommended that Egrifta (tesamorelin), Montreal-based Theratechnologies’ experimental product for the treatment of excess abdominal fat in HIV-positive people with lipodystrophy, be approved by the agency.  Though the FDA is not required to …

FDA Committee Unanimously Recommends Egrifta for Lipodystrophy Read More »

Vitamin and Mineral Use in HIV- Summary of Studies

 Excellent summary tables on the use of micronutrients in HIV published in Am J Clin Nutr 2007;85:333–45. Printed in USA. © 2007 American Society for Nutrition https://www.ajcn.org/cgi/content/full/85/2/333 Reference Study design, location, and population Vitamin concentrations1 Results and conclusions Cross-sectional studies     Toma et al, 2001 (93) Cross-sectional study in Canada. 11 HIV-positive adults (6 receiving HAART …

Vitamin and Mineral Use in HIV- Summary of Studies Read More »

The Forgotten Minority: HIV+ Patients With No Available HIV treatment Options

Most successful HIV medication combinations require 3 medications that are fully active, but a small portion of long term survivors with long treatment history and accumulated HIV resistance mutations do not have the luxury of constructing a viable regimen to save their lives. Several potent antiretrovirals (ARVs) in the past 4 years have enabled many …

The Forgotten Minority: HIV+ Patients With No Available HIV treatment Options Read More »

Scroll to Top